BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 25744370)

  • 1. Cis-Expression Quantitative Trait Loci Mapping Reveals Replicable Associations with Heroin Addiction in OPRM1.
    Hancock DB; Levy JL; Gaddis NC; Glasheen C; Saccone NL; Page GP; Hulse GK; Wildenauer D; Kelty EA; Schwab SG; Degenhardt L; Martin NG; Montgomery GW; Attia J; Holliday EG; McEvoy M; Scott RJ; Bierut LJ; Nelson EC; Kral AH; Johnson EO
    Biol Psychiatry; 2015 Oct; 78(7):474-84. PubMed ID: 25744370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cis-eQTL in OPRM1 is Associated with Subjective Response to Alcohol and Alcohol Use.
    Otto JM; Gizer IR; Deak JD; Fleming KA; Bartholow BD
    Alcohol Clin Exp Res; 2017 May; 41(5):929-938. PubMed ID: 28273335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A heroin addiction severity-associated intronic single nucleotide polymorphism modulates alternative pre-mRNA splicing of the μ opioid receptor gene OPRM1 via hnRNPH interactions.
    Xu J; Lu Z; Xu M; Pan L; Deng Y; Xie X; Liu H; Ding S; Hurd YL; Pasternak GW; Klein RJ; Cartegni L; Zhou W; Pan YX
    J Neurosci; 2014 Aug; 34(33):11048-66. PubMed ID: 25122903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low frequency genetic variants in the μ-opioid receptor (OPRM1) affect risk for addiction to heroin and cocaine.
    Clarke TK; Crist RC; Kampman KM; Dackis CA; Pettinati HM; O'Brien CP; Oslin DW; Ferraro TN; Lohoff FW; Berrettini WH
    Neurosci Lett; 2013 May; 542():71-5. PubMed ID: 23454283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multiancestry study identifies novel genetic associations with CHRNA5 methylation in human brain and risk of nicotine dependence.
    Hancock DB; Wang JC; Gaddis NC; Levy JL; Saccone NL; Stitzel JA; Goate A; Bierut LJ; Johnson EO
    Hum Mol Genet; 2015 Oct; 24(20):5940-54. PubMed ID: 26220977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional mu opioid receptor polymorphism (OPRM1 A(118) G) associated with heroin use outcomes in Caucasian males: A pilot study.
    Woodcock EA; Lundahl LH; Burmeister M; Greenwald MK
    Am J Addict; 2015 Jun; 24(4):329-35. PubMed ID: 25911999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Replication of ZNF804A gene variant associations with risk of heroin addiction.
    Hancock DB; Levy JL; Gaddis NC; Glasheen C; Saccone NL; Page GP; Bierut LJ; Kral AH; Johnson EO
    Genes Brain Behav; 2015 Nov; 14(8):635-40. PubMed ID: 26382569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The μ-opioid receptor nonsynonymous variant 118A>G is associated with prolonged abstinence from heroin without agonist treatment.
    Levran O; Peles E; Randesi M; da Rosa JC; Adelson M; Kreek MJ
    Pharmacogenomics; 2017 Oct; 18(15):1387-1391. PubMed ID: 28976288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OPRM1 rs1799971 polymorphism and opioid dependence: evidence from a meta-analysis.
    Haerian BS; Haerian MS
    Pharmacogenomics; 2013 May; 14(7):813-24. PubMed ID: 23651028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of the OPRM1 Variant rs1799971 (A118G) with Non-Specific Liability to Substance Dependence in a Collaborative de novo Meta-Analysis of European-Ancestry Cohorts.
    Schwantes-An TH; Zhang J; Chen LS; Hartz SM; Culverhouse RC; Chen X; Coon H; Frank J; Kamens HM; Konte B; Kovanen L; Latvala A; Legrand LN; Maher BS; Melroy WE; Nelson EC; Reid MW; Robinson JD; Shen PH; Yang BZ; Andrews JA; Aveyard P; Beltcheva O; Brown SA; Cannon DS; Cichon S; Corley RP; Dahmen N; Degenhardt L; Foroud T; Gaebel W; Giegling I; Glatt SJ; Grucza RA; Hardin J; Hartmann AM; Heath AC; Herms S; Hodgkinson CA; Hoffmann P; Hops H; Huizinga D; Ising M; Johnson EO; Johnstone E; Kaneva RP; Kendler KS; Kiefer F; Kranzler HR; Krauter KS; Levran O; Lucae S; Lynskey MT; Maier W; Mann K; Martin NG; Mattheisen M; Montgomery GW; Müller-Myhsok B; Murphy MF; Neale MC; Nikolov MA; Nishita D; Nöthen MM; Nurnberger J; Partonen T; Pergadia ML; Reynolds M; Ridinger M; Rose RJ; Rouvinen-Lagerström N; Scherbaum N; Schmäl C; Soyka M; Stallings MC; Steffens M; Treutlein J; Tsuang M; Wall TL; Wodarz N; Yuferov V; Zill P; Bergen AW; Chen J; Cinciripini PM; Edenberg HJ; Ehringer MA; Ferrell RE; Gelernter J; Goldman D; Hewitt JK; Hopfer CJ; Iacono WG; Kaprio J; Kreek MJ; Kremensky IM; Madden PA; McGue M; Munafò MR; Philibert RA; Rietschel M; Roy A; Rujescu D; Saarikoski ST; Swan GE; Todorov AA; Vanyukov MM; Weiss RB; Bierut LJ; Saccone NL
    Behav Genet; 2016 Mar; 46(2):151-69. PubMed ID: 26392368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mu Opioid Receptor Genetic Variation and Heroin Addiction.
    Zubieta JK
    Biol Psychiatry; 2015 Oct; 78(7):439-40. PubMed ID: 26360547
    [No Abstract]   [Full Text] [Related]  

  • 12. κ Opioid Receptor 1 Single Nucleotide Polymorphisms were Associated with the Methadone Dosage.
    Zhang Q; Shi M; Tang H; Zhong H; Lu X
    Genet Test Mol Biomarkers; 2020 Jan; 24(1):17-23. PubMed ID: 31940240
    [No Abstract]   [Full Text] [Related]  

  • 13. Association between rs1799971 in the mu opioid receptor gene and methadone maintenance treatment response.
    Xie X; Gu J; Zhuang D; Zhou Y; Chen X; Shen W; Li L; Liu Y; Xu W; Hong Q; Xu Z; Chen W; Zhou W; Liu H
    J Clin Lab Anal; 2022 Nov; 36(11):e24750. PubMed ID: 36305091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haplotype block structure of the genomic region of the mu opioid receptor gene.
    Levran O; Awolesi O; Linzy S; Adelson M; Kreek MJ
    J Hum Genet; 2011 Feb; 56(2):147-55. PubMed ID: 21160491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single nucleotide polymorphism in
    Koijam AS; Chakraborty B; Mukhopadhyay K; Rajamma U; Haobam R
    J Addict Dis; 2020; 38(2):214-222. PubMed ID: 32189578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutamatergic and GABAergic susceptibility loci for heroin and cocaine addiction in subjects of African and European ancestry.
    Levran O; Peles E; Randesi M; Correa da Rosa J; Ott J; Rotrosen J; Adelson M; Kreek MJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():118-23. PubMed ID: 26277529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of specific haplotypes of D2 dopamine receptor gene with vulnerability to heroin dependence in 2 distinct populations.
    Xu K; Lichtermann D; Lipsky RH; Franke P; Liu X; Hu Y; Cao L; Schwab SG; Wildenauer DB; Bau CH; Ferro E; Astor W; Finch T; Terry J; Taubman J; Maier W; Goldman D
    Arch Gen Psychiatry; 2004 Jun; 61(6):597-606. PubMed ID: 15184239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association study of OPRM1 polymorphisms with Schizophrenia in Han Chinese population.
    Ding S; Chen B; Zheng Y; Lu Q; Liu L; Zhuge QC
    BMC Psychiatry; 2013 Apr; 13():107. PubMed ID: 23560613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulated expression of the alternatively spliced variant mRNAs of the mu opioid receptor gene, OPRM1, in the medial prefrontal cortex of male human heroin abusers and heroin self-administering male rats.
    Brown TG; Xu J; Hurd YL; Pan YX
    J Neurosci Res; 2022 Jan; 100(1):35-47. PubMed ID: 32506472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stress-related genes and heroin addiction: a role for a functional FKBP5 haplotype.
    Levran O; Peles E; Randesi M; Li Y; Rotrosen J; Ott J; Adelson M; Kreek MJ
    Psychoneuroendocrinology; 2014 Jul; 45():67-76. PubMed ID: 24845178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.